Substance / Medication

Dantrolene sodium

Overview

Clinical overview including description, indications, and evidence base is pending physician authorship or FDA SPL integration. Graph-derived relationship data is available below.

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

Research Evidence

Published studies and systematic reviews

Sort:
Effect of oral administration of dantrolene sodium on serum creatine kinase activity after exercise in horses with recurrent exertional rhabdomyolysis.
McKenzie Erica C, Valberg Stephanie J, Godden Sandra M et al. · Am J Vet Res · 2004
PMID: 14719706Observational
Anti-inflammatory and antinociceptive properties of dantrolene sodium in rats and mice.
Büyükokuroğlu Mehmet Emin · Pharmacol Res · 2002
PMID: 12162945Observational
In vitro antioxidant properties of dantrolene sodium.
Büyükokuroğlu M E, GülçIn I, Oktay M et al. · Pharmacol Res · 2001
PMID: 11735355Observational
The efficacy of dantrolene sodium for muscle cramps in patients with localized scleroderma.
Nakamura K, Yoshizaki A, Saigusa R et al. · J Eur Acad Dermatol Venereol · 2016
PMID: 26559172Case Report
Dantrolene sodium for the treatment of aldesleukin-induced rigors in a melanoma patient.
Azari Laleh M, Sheehan Vivien S, Sachdev Jasgit C et al. · Ann Pharmacother · 2012
PMID: 22510667Case Report
[A case of status epilepticus with a possible therapeutic effect by dantrolene sodium].
Hiasa Atsunori, Sasaki Ryogen, Takeuchi Toshiaki et al. · Rinsho Shinkeigaku · 2011
PMID: 22019872Case Report
Severe acneiform eruption exacerbated by dantrolene sodium.
Mowbray M, Sinclair S A, Allan S J · Clin Exp Dermatol · 2009
PMID: 19187303Case Report

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Specialists

Providers who commonly manage this intervention

Health Goals

Goals connected through associated conditions

Quick Facts

Type
Substance / Medication
Fully Specified Name
Dantrolene sodium (substance)
SNOMED CT
81946009
UMLS CUI
C0010977

Clinical Data

This intervention maps to 11 entities in the Healos knowledge graph.

6
Conditions
3
Biomarkers
1
Specialists
0
Symptoms

Data is sourced from SNOMED CT, UMLS, and the Healos clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.

Dantrolene sodium — Conditions, Biomarkers & Specialists | Healos | Ltrl